- A new vaccine was tested for glioblastoma.
- The trial took place at a cancer center.
- The vaccine uses DNA to train the immune system.
- It teaches the body to find tumour proteins.
- Patients received injections after brain surgery.
- Most patients showed more immune-cell activity.
- One patient did not respond because of a steroid.
- Clinical results looked better than expected.
- One person is alive and cancer-free years later.
- Researchers plan larger studies to test the vaccine.
Difficult words
- glioblastoma — a serious cancer that starts in the brain
- vaccine — a medicine that helps the body fight disease
- immune system — the body's cells and organs that fight illness
- tumour — a mass of abnormal cells in the body
- injection — a medicine given with a needle into the bodyinjections
- steroid — a drug that reduces swelling and inflammation
- researcher — a person who studies and tests new ideasResearchers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever had an injection?
- Would you try a new vaccine if a doctor recommended it?
- Do you know someone who had brain surgery?
Related articles
Traditional African Diet Reduces Inflammation
A trial in Tanzania found that a traditional plant-based African diet lowered inflammation within two weeks, while a short-term Western diet increased inflammation and weakened immune responses. The results matter for rising non-communicable diseases in Sub-Saharan Africa.
Air pollution linked to higher post-surgery risks in Utah
A study of 49,615 non-emergency surgeries on Utah’s Wasatch Front found that higher PM2.5 in the week before surgery was associated with more post-surgical complications. The research appears in Acta Anaesthesiologica Scandinavica.
New drug pair helps fight rifampicin-resistant tuberculosis
Scientists paired rifampicin with a probe called AAP-SO2 that binds bacterial RNA polymerase at a different site and slows transcription. The pair killed resistant mutants in culture and was especially effective in a rabbit model.